American Heart News - Stroke News
JULY 2, 2024
DALLAS and MINNEAPOLIS, July 2, 2024 — The American Academy of Neurology and the American Heart Association have awarded the first-ever Ralph L. Sacco Scholarships for Brain Health to two researchers, Patrick Devlin, Ph.D., of Houston, Texas, and Cyprien.
Medical Xpress - Cardiology
JULY 2, 2024
A new study sheds light on a medical question scientists have long wondered: why do 40% of children with the rare neurodevelopmental disorder KBG syndrome have heart defects? The research now points to a critical link between the heart and the brain. The research is published in the journal Nature Communications.
HCPLive
JULY 2, 2024
Treatment involved repairing the brain tissue using HBOT, which led to significant symptom improvement.
Medical Xpress - Cardiology
JULY 2, 2024
The Mediterranean diet is a powerful ally for health even after a cancer diagnosis. This is the key result of an Italian study carried out as part of the UMBERTO Project, conducted by the Joint Research Platform Umberto Veronesi Foundation—Department of Epidemiology and Prevention of the I.R.C.C.S. Neuromed of Pozzilli, in collaboration with the LUM "Giuseppe Degennaro" University of Casamassima (BA).
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
DAIC
JULY 2, 2024
From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1. Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management 2. Landmark Clinical Study in The Lancet Finds New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation at Least 10 Years in Advance 3.
Med Page Today
JULY 2, 2024
(MedPage Today) -- Over 100 batches of potassium chloride are being recalled because they are not dissolving correctly, which may lead to hyperkalemia that can ultimately cause cardiac arrhythmias and death in some cases, per an FDA alert. And.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Medical Xpress - Cardiology
JULY 2, 2024
In 2012, Neil Armstrong, the first man to walk on the moon, died of post-surgery complications at the age of 82 following what should have been a routine heart surgery. Armstrong had undergone bypass surgery, the most common open-heart operation in the United States, and a surgery where the overall chance of death has dropped to almost zero.
JAMA Cardiology
JULY 2, 2024
This randomized clinical trial evaluates the safety and efficacy of lerodalcibep vs placebo in reduction of low-density lipoprotein cholesterol in patients with or at risk of cardiovascular disease.
Medical Xpress - Cardiology
JULY 2, 2024
Selecting specific cells to be used in an investigational therapy has led to improved recovery of heart function in a new study employing a lab model for myocardial infarction, the medical term for heart attacks.
American College of Cardiology
JULY 2, 2024
The following are key points to remember from a state-of-the-art review on practical guidance for hemodynamic assessment by right heart catheterization (RHC) in the management of heart failure (HF):
HCPLive
JULY 2, 2024
Our May 2024 month-in-review for hematology focuses on the latest updates to the hematologic pipeline.
American College of Cardiology
JULY 2, 2024
Many patients with severe, symptomatic tricuspid regurgitation (TR) may also present with advanced heart failure with preserved ejection fraction (HFpEF), and treatments for each condition may impact the other condition. A JACC State-of-the-Art Review on the topic, published on July 1, explores the relationship between these two conditions and proposes management strategies.
HCPLive
JULY 2, 2024
Shiffman reviews some of the key findings from AHFIRM, explaining important considerations for interpreting the results and potential reasons for regional differences in the data.
American College of Cardiology
JULY 2, 2024
Does the relationship between low-density lipoprotein cholesterol (LDL-C) lowering and cardiovascular (CV) benefit achieved with bempedoic acid resemble that observed with statins when standardized per unit change in LDL-C?
JAMA Cardiology
JULY 2, 2024
This case-control study investigates the ability of a large-scale proteomics panel from first-trimester blood samples to predict the development of hypertensive disorders of pregnancy.
HCPLive
JULY 2, 2024
The study demonstrated clinical similarity between the proposed biosimilar and the reference products.
American College of Cardiology
JULY 2, 2024
In this week’s View, Dr. Eagle looks at the clinical impact of early rhythm control and healthy lifestyles in patients with atrial fibrillation, then explores the use of low-dose aspirin in the prevention of atherosclerotic cardiovascular disease.
HCPLive
JULY 2, 2024
In this episode, Veeral Sheth, MD speaks with Alkeus Pharmaceutical's CMO on the company's lead candidate for Stargardt disease and the TEASE clinical trial program.
American College of Cardiology
JULY 2, 2024
One pivotal study, the phase 3 trial known as KEYNOTE-522, focused on previously untreated stage II or stage III triple-negative breast cancer patients.
HCPLive
JULY 2, 2024
Our Cardiology Month in Review for June 2024 spotlights the pharmacotherapies making waves within the pipeline, the latest news in dyslipidemia, and updates in heart failure.
American College of Cardiology
JULY 2, 2024
The goal of the LANDMARK trial was to evaluate transcatheter aortic valve replacement (TAVR) with the Myval prosthesis compared with a contemporary prosthesis among patients with symptomatic severe aortic stenosis.
HCPLive
JULY 2, 2024
Findings highlight the prognostic value of metabolic syndrome components in predicting both renal and cardiovascular outcomes in patients with IgA nephropathy.
American College of Cardiology
JULY 2, 2024
What is the effect of AT-001, an aldose reductase inhibitor, on exercise capacity among individuals with diabetic cardiomyopathy (DbCM) with reduced exercise capacity and at high risk for progression to overt heart failure (HF)?
HCPLive
JULY 2, 2024
HCPLive spoke with Joshua M. Cohen, MD, MPH, to discuss a post-hoc analysis of a phase 3 study that showed buprenorphine may be effective at reducing fentanyl use.
American College of Cardiology
JULY 2, 2024
In this interview, Diann Gaalema, PhD and Anthony N. DeMaria, MD, MACC discuss financial incentives to improving cardiac rehab participation.
HCPLive
JULY 2, 2024
The panel concludes the discussion with key takeaways on the evolving treatment landscape for COPD.
Journal of Cardiothoracic Surgery
JULY 2, 2024
Background Evaluating outcomes of concurrent Cox-Maze procedures in elderly patients undergoing high-risk cardiac surgery. Mehods We retrospectively identified patients aged over 70 years with Atrial Fibrillation (AF) from 2011 to 2017 who had two or more other cardiac procedures. They were subdivided into two groups: 1. Cox-Maze IV AF ablation. 2. No-Surgical AF treatment.
HCPLive
JULY 2, 2024
This Month in Review spotlights interviews conducted at SLEEP 2024 and a recent FDA approval.
Journal of Cardiothoracic Surgery
JULY 2, 2024
The occurrence of type II endoleaks after endovascular repair of aortic aneurysm has gradually gained increasing attention. We present a case of a patient with an expanding aneurysm after thoracic endovascular.
HCPLive
JULY 2, 2024
In this clinical quiz, you will test your knowledge of psoriasis guidelines, with special focus on important clinical questions related to management of psoriasis and recent evidence-based recommendations.
Journal of Cardiothoracic Surgery
JULY 2, 2024
Extracorporeal circulation causes a systemic inflammatory response, that may cause postoperative haemodynamic instability and end-organ dysfunction. This study aimed to investigate the impact of minimal invasi.
Dr. S. Venkatesan MD
JULY 2, 2024
I don’t want to do this …but EBM compels me to do it The word “Evidence” is the most powerful in the world of science and enjoys disproportionate bias towards positivity (of course in any walk of life). But, the fact of the matter is, it can result in either monumental breakthroughs or mindless havoc to mankind in equal quantities.
Journal of Cardiothoracic Surgery
JULY 2, 2024
Although mitral valve repair is the preferred surgical strategy in children with mitral valve disease, there are cases of irreparable severe dysplastic valves that require mitral valve replacement. The aim of.
HCPLive
JULY 2, 2024
Addressing patients with HIV who have fallen out of care, Shauna Applin, ARNP, provides clinical insights on treatment options and best practices for restarting therapy.
Medical Xpress - Cardiology
JULY 2, 2024
Exercise testing can serve as a powerful physiologic probe to unmask subclinical cardiovascular abnormalities well before disease onset. For example, blood pressure changes during exercise (EBP) can reveal a latent tendency toward future development of hypertension. At present, there is no reliable circulating biomarker—a protein or other molecule present in the blood stream—indicative of hypertension risk.
Frontiers in Cardiovascular Medicine
JULY 2, 2024
Cardiovascular diseases account for a significant portion of the worldwide mortality rate. This aroused interest among the specialised scientific community, seeking for solutions based on non-clinical and clinical investigations, to shed light onto the physio-pathology of cardiovascular impairment. It is proven challenging managing chronic cardiovascular illnesses like atherosclerosis, arrhythmias, and diverse cardiomyopathies.
Expert insights. Personalized for you.
134 
Let's personalize your content